Social Impact

Cure Brain Cancer

Unleashing the power of analytics to identify drivers of survival for brain cancer patients

The Cure Brain Cancer Foundation (‘CBCF’) is the leading organization for brain cancer research, advocacy and awareness in Australia, with a time-critical mission to increase the five-year survival rate of brain cancer patients from the current 20 percent to 50 percent by 2023. With an increasing volume of data relating to brain cancer epidemiology, CBCF are looking to leverage advanced analytical techniques to help unveil meaningful insights from this data – with a view to identify any lifestyle, treatment or other factors which may be correlated with increased survivalrates.

I am very excited of our collaboration with CBCF, as I believe Oliver Wyman can add substantial value in aggregating and interpreting the increasing volume of data on brain cancer in order to identify drivers of survival. It is a cause that is very dear to my heart, and one where Oliver Wyman’s capabilities are a perfect complement to CBCF, who have limited experience in analyzing epidemiologic data. Increasing the understanding of the disease to better fight it will be impactful and make a substantial difference to thousands
Andrea Zannier, Partner, Oliver Wyman


CBCF engaged Oliver Wyman to help in identifying and connecting/aggregating brain cancer-related data sources at a global level, with the intent to create a broad and growing pool of data that can be analyzed to identify drivers of increasing survival and other valuable insight. The goal for Cure Brain Cancer Foundation is to help address the key question: “Which are the drivers that explain longer survival in brain cancer patients?” Phase 1 of the project was aimed at identifying which data sources related to brain cancer are currently available globally; Phase 2 will focus on identifying opportunities for aggregating and using advanced analytics to identify statistically significant drivers that explain longer survival in patients with brain cancer.

The next phase for us is drafting a project proposal to approach the data agencies for early next year as part of the next stage of the research plan, and we look forward to continuing our collaboration with you in 2018
Michelle Stewart, Chief Executive Officer, Cure Brain Cancer


There are two key desired outcomes. First to create an aggregated epidemiologic data repository that can be mined for scientific purposes, and in particular identify drivers of brain cancer survival. Then perform analytics to identify statistically significant drivers of brain cancer survival that can improve treatment.